Crossmark Global Holdings Inc. bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the third quarter, according to its most recent filing with the SEC. The firm bought 30,385 shares of the medical instruments supplier’s stock, valued at approximately $1,817,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Veritas Asset Management LLP lifted its holdings in shares of DENTSPLY SIRONA by 2.6% in the 2nd quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock worth $402,083,000 after purchasing an additional 157,616 shares in the last quarter. Royce & Associates LP lifted its holdings in shares of DENTSPLY SIRONA by 23.4% in the 2nd quarter. Royce & Associates LP now owns 126,650 shares of the medical instruments supplier’s stock worth $8,212,000 after purchasing an additional 24,000 shares in the last quarter. Bronfman E.L. Rothschild L.P. lifted its holdings in shares of DENTSPLY SIRONA by 78.7% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 11,886 shares of the medical instruments supplier’s stock worth $771,000 after purchasing an additional 5,236 shares in the last quarter. Gateway Investment Advisers LLC lifted its holdings in shares of DENTSPLY SIRONA by 8.4% in the 2nd quarter. Gateway Investment Advisers LLC now owns 19,408 shares of the medical instruments supplier’s stock worth $1,258,000 after purchasing an additional 1,499 shares in the last quarter. Finally, Delta Lloyd Asset Management N.V. bought a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth $15,624,000. Institutional investors own 93.71% of the company’s stock.

A number of equities analysts recently issued reports on the company. Stifel Nicolaus increased their target price on DENTSPLY SIRONA from $66.00 to $70.00 and gave the stock a “buy” rating in a report on Monday. Barrington Research upgraded DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 target price on the stock in a report on Monday. HC Wainwright reiterated a “buy” rating and issued a $68.00 target price (down from $74.00) on shares of DENTSPLY SIRONA in a report on Monday, August 14th. TheStreet upgraded DENTSPLY SIRONA from a “c” rating to a “b-” rating in a report on Friday, November 3rd. Finally, UBS AG restated a “neutral” rating and set a $59.00 price objective (down from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $67.00.

COPYRIGHT VIOLATION NOTICE: “Crossmark Global Holdings Inc. Buys Shares of 30,385 DENTSPLY SIRONA Inc. (XRAY)” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/11/08/crossmark-global-holdings-inc-buys-shares-of-30385-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Inc. (XRAY) opened at $64.38 on Wednesday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. DENTSPLY SIRONA Inc. has a 52 week low of $52.53 and a 52 week high of $67.95. The firm has a market capitalization of $14,658.28, a price-to-earnings ratio of 25.45, a price-to-earnings-growth ratio of 2.62 and a beta of 1.27.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The business had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $978.99 million. During the same period last year, the business earned $0.66 EPS. The business’s revenue was up 5.8% on a year-over-year basis. equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 2.67 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.